|
The U.S. Department of Health and Human Services (HHS) has recommended that the Drug Enforcement Administration (DEA) ease federal restrictions on marijuana. The HHS recommendation suggests moving marijuana from a Schedule I drug to Schedule III, which would have significant implications for the industry, including the ability to deduct ordinary business expenses for tax purposes. This move comes after President Joe Biden ordered a review of marijuana policy, and it is seen as a significant step toward aligning federal law with the growing number of states that have legalized marijuana in some form. However, the ultimate decision rests with the DEA, and the timing of any potential rescheduling remains uncertain.
|
The opioid overdose antidote Narcan will soon be available over the counter at major retailers, including Walgreens, Walmart, Rite Aid, and CVS, as well as online. This move aims to increase access to Narcan to combat the rising number of overdose deaths in the United States, which reached an all-time high in 2021. However, the cost of a two-pack of Narcan, priced at $44.99, has raised concerns that it may be out of reach for some individuals, limiting its accessibility to those who need it most.
|
A study has found that patients could save millions of dollars by purchasing prescription drugs through online pharmacy discount programs like Amazon Pharmacy or GoodRx, compared to traditional insurance plans. Researchers at the University of Toledo College of Pharmacy and Pharmaceutical Sciences in Ohio analyzed 20 commonly prescribed generic drugs and found that at least 1 out of 5 prescriptions were cheaper through these discount programs. The potential savings were estimated at about $969 million for Amazon Pharmacy users and about $1.83 billion for GoodRx users. This study highlights the potential benefits of such online pharmacy discount programs for reducing out-ofpocket costs for Americans, particularly those without adequate insurance coverage.
|
The U.S. Food and Drug Administration (FDA) has announced that it still plans to finalize rules that would prohibit the sale of menthol cigarettes and flavored cigars this year, but the agency is running behind schedule. The deadline to work out the details of this ban was originally set for August 2023, but the FDA now states that it will complete work on the rule "in the coming months." Many public health leaders have expressed frustration with the lengthy process, as they believe that regulations on menthol, the last flavor allowed in cigarettes, are urgently needed to reduce the harms associated with smoking.
|
Roz Brewer has stepped down as the CEO of Walgreens Boots Alliance, leaving the company's board as well. This decision was characterized as mutual, and Ginger Graham, the lead independent director and a healthcare industry veteran, will serve as interim chief while the company searches for a replacement. Brewer had led Walgreens since March 2021 and during her tenure, the company pursued a transition to position itself more as a healthcare company rather than a pharmacy chain. However, Walgreens has struggled with a drop in demand for COVID-19 testing and vaccines, and its retail sales have faced strong competition from retailers like Walmart and Amazon. As Walgreens aims to become more of a healthcare provider, Brewer's skillset was seen as less aligned with the company's goals. This transition aligns with a broader industry trend of pharmacy chains seeking to expand their healthcare services and offerings.
|
|